Canopy Growth CGC
NASDAQ CGC
$1.03 0.00 (-0.48%)
At close: Aug 20, 2026 · 12:58 PM UTC

Canopy Growth (CGC) Asset Writedowns and Impairment (2020 - 2023)

Canopy Growth (CGC) posted Asset Writedowns and Impairment of $7.9 million for Q2 2023, down 97.14% sequentially from $275.7 million in Q1 2023, and down 99.42% YoY from $1.4 billion in Q2 2022.

Canopy Growth (CGC) Asset Writedowns and Impairment (2020 - 2023) Analysis & Trends

Canopy Growth has reported Asset Writedowns and Impairment for 4 years, with the latest figure at $7.9 million in Q2 2023.

  • Quarterly Asset Writedowns and Impairment fell 99.42% year-over-year to $7.9 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $379.0 million (down 75.59% YoY) and the FY2023 annual result came in at $1.6 billion, up 526.97% from the prior year.
  • Asset Writedowns and Impairment slipped to $7.9 million in Q2 2023 per CGC's latest filing, from $275.7 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $1.4 billion in Q2 2022 and troughed at -$809503.1 in Q3 2021.
  • A 4-year average of $209.4 million and a median of $76.3 million in 2021 frame the typical range for Asset Writedowns and Impairment.
  • The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment jumped 10927.04% in 2022, then tumbled 99.42% in 2023.
  • Over 4 years, Asset Writedowns and Impairment stood at $228.7 million in 2020, then slumped by 88.71% to $25.8 million in 2021, then plunged by 69.77% to $7.8 million in 2022, then grew by 0.88% to $7.9 million in 2023.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $7.9 million, $275.7 million, and $7.8 million for Q2 2023, Q1 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.96 Bn 43.00 Bn -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 Canopy Growth 434.93 Mn 187.92 Mn 16.08 Mn

Historic Data

Download Data
DateValue
Jun 30, 2023 7.88 Mn
Jun 30, 2023 7.88 Mn
Mar 31, 2023 275.71 Mn
Mar 31, 2023 275.71 Mn
Dec 31, 2022 7.81 Mn
Dec 31, 2022 7.81 Mn
Sep 30, 2022 87.65 Mn
Sep 30, 2022 87.65 Mn
Jun 30, 2022 1.35 Bn
Jun 30, 2022 1.35 Bn
Mar 31, 2022 173.45 Mn
Mar 31, 2022 173.45 Mn
Dec 31, 2021 25.83 Mn
Dec 31, 2021 25.83 Mn
Sep 30, 2021 -809,503.09
Sep 30, 2021 -809,503.09
Jun 30, 2021 66.47 Mn
Jun 30, 2021 66.47 Mn
Mar 31, 2021 76.32 Mn
Mar 31, 2021 76.32 Mn